Blog

  • Acute severe ulcerative colitis: an overview for physicians

    Acute severe ulcerative colitis is one of the true emergencies of gastroenterology. It can affect patients with known colitis or be the first presentation of the disease, and it still carries a real risk of colectomy. Any physician who admits patients on the medical take should be able to recognise it.

    Recognition

    The modified Truelove and Witts criteria are used to define a severe attack. They combine the number of bloody stools a day with signs of systemic upset, such as a fast pulse, fever, anaemia or raised inflammatory markers. The criteria are simple to apply at the bedside and appear frequently in exams.

    Why it is an emergency

    Severe colitis can progress to toxic dilatation of the colon, perforation, bleeding and sepsis. Patients are also at increased risk of venous thromboembolism. Delay in recognising severity, or in involving the right teams, is a recognised cause of harm.

    Things to exclude

    Infection can mimic or complicate a flare. Stool tests, including testing for Clostridioides difficile, are part of the initial assessment, and biopsies help to look for cytomegalovirus in selected patients.

    A joint approach

    Patients with acute severe colitis are cared for by gastroenterologists and colorectal surgeons together from the start, with regular joint review. Patients and families should be involved early in discussions about the possible outcomes, including surgery, so that decisions are not made in a hurry.

    For exams and for practice

    Exam questions usually test recognition of severity, the importance of excluding infection, and the role of planned reassessment. In practice, the same priorities apply: early recognition, early specialist involvement and clear communication.

    IBD for Clinicians covers acute severe colitis alongside the other IBD emergencies, with the scores and decision points explained for clinicians.

  • Treat to target in IBD: the idea behind modern monitoring

    For many years, success in inflammatory bowel disease was judged by how the patient felt. If the diarrhoea settled and the pain eased, all was well. We now know that symptoms and inflammation do not always move together. A patient can feel well while inflammation continues to damage the bowel.

    Treat to target is the response to that discovery. It means agreeing measurable goals at the start, checking them at planned times, and reviewing the plan with the IBD team when a goal is not met.

    The targets

    Targets are usually layered by time. In the short term the aim is relief of symptoms. Blood and stool markers of inflammation should then return to normal. In the longer term the aim is healing of the bowel lining, because mucosal healing is linked with fewer flares, fewer admissions and less surgery. Quality of life and the absence of disability sit alongside these goals.

    How the targets are measured

    Faecal calprotectin is the workhorse of monitoring. It is non-invasive, can be repeated, and often rises before symptoms return. C-reactive protein helps in some patients. Endoscopy remains the reference standard for assessing healing, and intestinal ultrasound and MR enterography are increasingly used to assess the small bowel in Crohn’s disease.

    Why the idea matters

    The value of treat to target lies in planning. Each check has a date, each result is compared with the agreed goal, and the patient knows what is being measured and why. It turns follow-up from waiting for the next flare into a structured conversation.

    For exams and for practice

    Treat to target is now part of the language of IBD in guidelines and in specialty exams. Physicians are expected to know what the targets are, how they are measured and how the scores used in IBD relate to them.

    IBD for Clinicians explains the targets, the scores used to measure them and the monitoring tools in line with the 2025 BSG guideline.

  • IBD for Clinicians: what the book covers and who it is for

    Caring for someone with inflammatory bowel disease is no longer only about controlling diarrhoea and pain. The aim of modern treatment is sustained, steroid-free remission, prevention of bowel damage, and protection of nutrition, function and quality of life. Reaching that aim depends on getting many decisions right: the diagnosis, the choice of drug, the timing of escalation, and the monitoring that follows.

    IBD for Clinicians was written to bring those decisions together in one place, updated against the 2025 British Society of Gastroenterology guideline on IBD in adults.

    What is inside

    • Diagnosis and classification, with a defensible strategy for biopsies and imaging.
    • Disease activity scores worked through, including Truelove and Witts, Mayo, the Harvey-Bradshaw Index, CDAI, SES-CD, Rutgeerts and PUCAI.
    • Treatment strategy for ulcerative colitis and Crohn’s disease.
    • Thiopurines and methotrexate, including TPMT and NUDT15 testing and metabolite interpretation.
    • Biologics and small molecules with current UK dosing and NICE and MHRA positions, plus therapeutic drug monitoring.
    • Emergencies, including acute severe colitis.
    • Perianal disease, surgery and pouchitis.
    • Pregnancy, vaccination and infection prevention.
    • Extraintestinal manifestations, nutrition and iron.
    • Treat-to-target monitoring and colorectal cancer surveillance.

    Who it is for

    The book is a working companion for gastroenterology trainees and consultants, IBD specialist nurses, pharmacists and general physicians who see patients with IBD on the ward or in clinic. It is also written with exams in mind: the scores and treatment pathways are the ones candidates are expected to know for specialty examinations.

    It is not a replacement for local protocols or for the full guideline. It is designed to sit beside them, so that the essentials of current UK practice are quick to find when a decision has to be made.

    IBD for Clinicians is available as a Kindle eBook and a paperback on Amazon.

  • How to revise for Best of Five exams

    Best of Five, or single best answer, questions are used in most postgraduate and licensing medical exams. Each question gives a clinical scenario and five options that are often all plausible. Your job is to pick the best one. That format rewards clinical reasoning far more than memorised facts, and it changes how you should revise.

    1. Read the notes before the questions

    Going straight to a question bank feels productive, but without a framework each question is an isolated fact. Spend a short session on the topic first: the key presentations, the first-line investigation, the first-line treatment and the common traps. Then do the questions on that topic. You will recognise patterns instead of guessing.

    2. Read every explanation, including the ones you got right

    A correct answer chosen for the wrong reason will fail you next time. The explanation is where the learning happens. Check why the right answer is best and why each of the other four is worse. Those wrong options are often the right answer to a different question.

    3. Keep an error log

    Write down every question you get wrong in one line: the topic, what you chose, what was correct, and the rule you missed. Review the log weekly. Within a few weeks you will see that most of your mistakes fall into a small number of themes, and those themes are where your marks are.

    4. Learn the guidelines the exam is written from

    Exam answers follow current guidance. For UK exams that means NICE and the specialty society guidelines. When a question asks for the next step or the first-line drug, the answer is usually the one the guideline names. Revising from up-to-date sources matters more than revising from many sources.

    5. Practise with images

    Many questions now include a radiograph, an endoscopy picture, a skin finding or a histology slide. Recognition comes from seeing many examples, so make sure your practice material includes clinical images and not only text.

    6. Move to timed practice

    Early on, work untimed and learn. In the final weeks, switch to timed blocks that match the exam, roughly one to one and a half minutes per question. Finish with at least two full mock papers so that stamina and timing are not a surprise on the day.

    7. Spread it out

    Short daily sessions beat long weekend sessions. Return to each specialty several times over the revision period rather than finishing it once and moving on. Repetition at intervals is what makes knowledge stick under exam pressure.

    Where the books fit

    The Clinical Medicine Review series is built around this method. Each book opens every chapter with concise revision notes, then gives Best of Five questions on that topic, and every answer comes with a discussion of the diagnosis, investigations and management. Clinical images and teaching diagrams are included throughout. Gastroenterology, Neurology and Respiratory Medicine are available now on Amazon as Kindle eBooks and paperbacks.

    For timed online practice, the question banks at License Medical work alongside the books.